{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:18:31Z","timestamp":1786569511486,"version":"build-2736575974"},"reference-count":140,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.alit.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T01:58:55Z","timestamp":1679450335000},"page":"207-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Executive summary: Japanese guidelines for adult asthma (JGL) 2021"],"prefix":"10.1016","volume":"72","author":[{"given":"Akio","family":"Niimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Tagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2023.02.006_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2332\/allergolint.10-OA-0282","article-title":"Time trend in the prevalence of adult asthma in Japan: findings from population-based surveys in Fujieda City in 1985, 1999, and 2006","volume":"60","author":"Fukutomi","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.alit.2019.04.009","article-title":"Impact of airflow obstruction on long-term mortality in patients with asthma in Japan","volume":"68","author":"Okayama","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1164\/rccm.201804-0682CI","article-title":"Underdiagnosis and overdiagnosis of asthma","volume":"198","author":"Aaron","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib4","series-title":"Global Strategy for Asthma Management and Prevention","year":"2020"},{"key":"10.1016\/j.alit.2023.02.006_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2016.19627","article-title":"Reevaluation of diagnosis in adults with physician-diagnosed asthma","volume":"317","author":"Aaron","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.alit.2023.02.006_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.alit.2017.06.013","article-title":"Development of a questionnaire to evaluate asthma control in Japanese asthma patients","volume":"67","author":"Tohda","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1399-3003.2000.15b05.x","article-title":"Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre","volume":"15","author":"Ichinose","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2023.02.006_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2169\/internalmedicine.47.0855","article-title":"Peak expiratory flow variability adjusted by forced expiratory volume in one second is a good index for airway responsiveness in asthmatics","volume":"47","author":"Matsunaga","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.alit.2023.02.006_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2332\/allergolint.10-OA-0277","article-title":"Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects","volume":"60","author":"Matsunaga","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib10","first-page":"1071","article-title":"[Evaluation of antigen specific IgE responses in Japanese asthmatics and non-asthmatics]","volume":"53","author":"Takahashi","year":"2004","journal-title":"Arerugi"},{"key":"10.1016\/j.alit.2023.02.006_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.alit.2021.08.009","article-title":"Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population","volume":"71","author":"Tanaka","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13223-021-00514-9","article-title":"Comprehensive analysis of allergen-specific IgE in COPD: mite-specific IgE specifically related to the diagnosis of asthma-COPD overlap","volume":"17","author":"Toyota","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.alit.2017.02.013","article-title":"Predicting future risk of exacerbations in Japanese patients with adult asthma: a prospective 1-year follow up study","volume":"66","author":"Tanaka","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib14","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.jaip.2019.04.046","article-title":"Factors associated with physician-patient discordance in the perception of asthma control","volume":"7","author":"Matsunaga","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2023.02.006_bib15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1164\/rccm.201911-2263OC","article-title":"Increased capsaicin sensitivity in patients with severe asthma is associated with worse clinical outcome","volume":"201","author":"Kanemitsu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1398-9995.2011.02676.x","article-title":"Prevalence and impact of rhinitis in asthma. SACRA, a cross- sectional nation-wide study in Japan","volume":"66","author":"Ohta","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaip.2013.09.018","article-title":"Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation","volume":"2","author":"Oka","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2023.02.006_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.resinv.2018.07.003","article-title":"Obesity-associated severe asthma in an adult Japanese population","volume":"56","author":"To","year":"2018","journal-title":"Respir Investig"},{"issue":"3 Pt 1","key":"10.1016\/j.alit.2023.02.006_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0091-6749(99)70327-1","article-title":"Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist","volume":"104","author":"Nakasato","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2332\/allergolint.10-OA-0239","article-title":"Correlation between Asian dust storms and worsening asthma in Western Japan","volume":"60","author":"Watanabe","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1081-1206(10)63289-9","article-title":"Inhibitory effects of azelastine hydrochloride in alcohol- induced asthma","volume":"82","author":"Takao","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2332\/allergolint.54.305","article-title":"Prevention of asthma exacerbation with vaccination against influenza in winter season","volume":"54","author":"Watanabe","year":"2005","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.alit.2019.06.003","article-title":"Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41533-020-00192-x","article-title":"Association of low-dosage systemic corticosteroid use with disease burden in asthma","volume":"30","author":"Matsunaga","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12890-017-0450-2","article-title":"Prognostic nomogram for inpatients with asthma exacerbation","volume":"17","author":"Hasegawa","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.alit.2023.02.006_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1440-1592.2004.00334.x","article-title":"Current asthma deaths among adults in Japan","volume":"53","author":"Nakazawa","year":"2004","journal-title":"Allegol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/ajrccm\/142.4.832","article-title":"Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid- dependent asthmatics","volume":"142","author":"Juniper","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.alit.2023.02.006_bib28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199409153311103","article-title":"Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma","volume":"331","author":"Haahtela","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1164\/ajrccm\/145.4_Pt_1.890","article-title":"Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study","volume":"145","author":"Jeffery","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.alit.2023.02.006_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids establishing therapy (FACET) international study group","volume":"337","author":"Pauwels","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.rmed.2003.10.007","article-title":"Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study","volume":"98","author":"Selroos","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jaci.2003.09.025","article-title":"Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma","volume":"112","author":"Sullivan","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib33","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1164\/ajrccm.155.6.9196087","article-title":"Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study","volume":"155","author":"Olivieri","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM200008033430504","article-title":"Low-dose inhaled corticosteroids and the prevention of death from asthma","volume":"343","author":"Suissa","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(03)12891-7","article-title":"Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial","volume":"361","author":"Pauwels","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2023.02.006_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib38","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/all.13874","article-title":"Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden","volume":"74","author":"Ekstr\u00f6m","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.alit.2020.04.003","article-title":"The impact of budesonide inhalation suspension for asthma hospitalization: in terms of length of stay, recovery time from symptoms, and hospitalization costs","volume":"69","author":"Ito","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/thorax.57.3.226","article-title":"Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma","volume":"57","author":"Chalmers","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2023.02.006_bib42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0091-6749(98)70241-6","article-title":"Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study","volume":"101","author":"Aaronson","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/thx.54.3.223","article-title":"One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density","volume":"54","author":"Hughes","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2023.02.006_bib44","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1067\/mai.2003.1340","article-title":"Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide","volume":"111","author":"Norjavaara","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1124\/pr.111.004580","article-title":"Pharmacology and therapeutics of bronchodilators","volume":"64","author":"Cazzola","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.alit.2023.02.006_bib46","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1716868","article-title":"Combined analysis of asthma safety trials of long-acting beta2-agonists","volume":"378","author":"Busse","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(94)92996-3","article-title":"Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen Hanburys Limited UK Study Group","volume":"344","author":"Greening","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2023.02.006_bib48","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.rmed.2008.01.021","article-title":"Comparison of salmeterol\/fluticasone propionate (FP) combination with FP\u00a0+ sustained release theophylline in moderate asthma patients","volume":"102","author":"Adachi","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2332\/allergolint.54.615","article-title":"Effect of transdermal tulobuterol added to inhaled corticosteroids in asthma patients","volume":"54","author":"Tamura","year":"2005","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib50","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib53","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib54","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jaip.2018.01.016","article-title":"Tiotropium attenuates refractory cough and capsaicin cough reflex sensitivity in patients with asthma","volume":"6","author":"Fukumitsu","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2023.02.006_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1067\/mai.2003.1558","article-title":"Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers","volume":"112","author":"Nelson","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1183\/09031936.02.00283202","article-title":"Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids","volume":"19","author":"Barnes","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2023.02.006_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-2600(13)70007-9","article-title":"Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial","volume":"1","author":"Patel","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib58","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(17)32397-8","article-title":"Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomized controlled trial","volume":"390","author":"Woodcock","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2023.02.006_bib59","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1183\/09031936.00186510","article-title":"Effect of different asthma treatments on risk of cold-related exacerbations","volume":"38","author":"Reddel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2023.02.006_bib60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2023.02.006_bib61","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib62","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol- glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double- blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib64","doi-asserted-by":"crossref","first-page":"106021","DOI":"10.1016\/j.rmed.2020.106021","article-title":"Fixed-dose combination of indacaterol\/glycopyrronium\/mometasone furoate once-daily versus salmeterol\/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: a randomised, Phase IIIb, non-inferiority study (ARGON)","volume":"170","author":"Gessner","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib65","doi-asserted-by":"crossref","first-page":"2004233","DOI":"10.1183\/13993003.04233-2020","article-title":"Triple therapy in uncontrolled asthma: a network meta-analysis of Phase III studies","volume":"58","author":"Rogliani","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2023.02.006_bib66","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/ajrccm.155.4.9105060","article-title":"Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi Idai Asthma Research Group","volume":"155","author":"Tamaoki","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib67","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1046\/j.1365-2745.2002.01440.x","article-title":"Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients","volume":"32","author":"Tohda","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib68","first-page":"CD003137","article-title":"Addition to inhaled corticosteroids of long-acting \u03b22 -agonists versus anti-leukotrienes for chronic asthma","volume":"24","author":"Chauhan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2023.02.006_bib69","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1010846","article-title":"Leukotriene antagonists as first-line or add-on asthma- controller therapy","volume":"364","author":"Price","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib70","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","volume":"188","author":"Barnes","year":"2013","journal-title":"Theophylline Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): innovate","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib72","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib73","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib74","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/all.12922","article-title":"Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma","volume":"71","author":"Tajiri","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib75","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1398-9995.2010.02522.x","article-title":"Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma","volume":"66","author":"Bousquet","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib76","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chest.2020.08.2083","article-title":"Real-World effectiveness of benralizumab in severe eosinophilic asthma","volume":"159","author":"Kavanagh","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.alit.2023.02.006_bib77","doi-asserted-by":"crossref","first-page":"2000151","DOI":"10.1183\/13993003.00151-2020","article-title":"Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis","volume":"56","author":"Harrison","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2023.02.006_bib78","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2023.02.006_bib79","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib80","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib81","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib82","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.clinthera.2019.07.007","article-title":"Long-term safety and clinical benefit of mepolizumab in patients with the most severe eosinophilic asthma: the COSMEX Study","volume":"41","author":"Khurana","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.alit.2023.02.006_bib83","doi-asserted-by":"crossref","first-page":"1800936","DOI":"10.1183\/13993003.00936-2018","article-title":"Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma","volume":"52","author":"Bleecker","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2023.02.006_bib84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cea.13491","article-title":"Mechanisms of dupilumab","volume":"50","author":"Harb","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.alit.2020.01.002","article-title":"Dupilumab: basic aspects and applications to allergic diseases","volume":"69","author":"Matsunaga","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.02.006_bib86","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib87","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib88","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.resinv.2021.01.007","article-title":"JRS guidelines for the management of cough and sputum","volume":"59","author":"Mukae","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.alit.2023.02.006_bib89","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib90","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2023.02.006_bib91","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib92","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib93","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2213-2600(20)30412-4","article-title":"Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials","volume":"9","author":"Brightling","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib94","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2023.02.006_bib95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American thoracic society\/European respiratory society statement: asthma control and exacerbations","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib96","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200407-884OC","article-title":"Budesonide\/formoterol combination therapy as both maintenance and reliever medication in asthma","volume":"171","author":"O'Byrne","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib97","first-page":"CD002738","article-title":"Inhaled beclomethasone versus placebo for chronic asthma","volume":"2005","author":"Adams","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2023.02.006_bib98","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifying the leukotriene pathway","volume":"340","author":"Drazen","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"6 Pt 1","key":"10.1016\/j.alit.2023.02.006_bib99","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1067\/mai.2000.106043","article-title":"Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma","volume":"105","author":"Bleecker","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/rmed.2001.1280","article-title":"Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms","volume":"96","author":"Dahl","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib101","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(94)90127-9","article-title":"Anti-inflammatory effects of low-dose oral theophylline in atopic asthma","volume":"343","author":"Sullivan","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2023.02.006_bib102","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.285.20.2594","article-title":"Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial","volume":"285","author":"Lemanske","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.alit.2023.02.006_bib103","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pupt.2012.10.006","article-title":"Difference in time-course of improvement in asthma control measures between budesonide and budesonide\/formoterol","volume":"26","author":"Matsunaga","year":"2013","journal-title":"Pulm Pharamcol Ther"},{"key":"10.1016\/j.alit.2023.02.006_bib105","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.rmed.2007.06.013","article-title":"Initiation of maintenance treatment with salmeterol\/fluticasone propionate 50\/100\u03bcg bd versus fluticasone propionate 100\u03bcg bd alone in patients with persistent asthma: integrated analysis of four randomised trials","volume":"101","author":"Barnes","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib106","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaip.2015.08.017","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2023.02.006_bib107","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.rmed.2014.06.011","article-title":"Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study","volume":"108","author":"Vogelberg","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib108","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1067\/mai.2000.110920","article-title":"Fluticasone propionate\/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast","volume":"106","author":"Nelson","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib109","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.327.7420.891","article-title":"Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial","volume":"327","author":"Bjermer","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.alit.2023.02.006_bib110","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199711133372002","article-title":"A\u00a0comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma","volume":"337","author":"Evans","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib111","doi-asserted-by":"crossref","first-page":"e0124109","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium respimat\u00ae is well tolerated and maitains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2023.02.006_bib112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2466-9-10","article-title":"Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis","volume":"9","author":"Dal Negro","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.alit.2023.02.006_bib113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pupt.2004.09.033","article-title":"Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma","volume":"18","author":"Vatrella","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.alit.2023.02.006_bib114","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaci.2016.08.009","article-title":"Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: clinical and histopathologic correlations","volume":"139","author":"Pretolani","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib115","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/rccm.201811-2064LE","article-title":"Persistent reduction of mucin production after bronchial thermoplasty in severe asthma","volume":"199","author":"Salem","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib116","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201911-2298OC","article-title":"Bronchial thermoplasty induced airway smooth muscle reduction and clinical response in severe asthma. The TASMA randomized trial","volume":"203","author":"Goorsenberg","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib117","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.200903-0354OC","article-title":"Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial","volume":"181","author":"Castro","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2023.02.006_bib118","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaci.2013.08.009","article-title":"Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma","volume":"132","author":"Wechsler","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib119","doi-asserted-by":"crossref","first-page":"95","DOI":"10.35772\/ghm.2019.01027","article-title":"Treatment for intractable asthma; bronchial thermoplasty","volume":"1","author":"Sugiyama","year":"2019","journal-title":"Glob Health Med"},{"key":"10.1016\/j.alit.2023.02.006_bib120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/L17-0748","article-title":"Bronchial thermoplasty for severe asthmatic cough","volume":"169","author":"Kanemitsu","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.alit.2023.02.006_bib121","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(20)30408-2","article-title":"Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials","volume":"9","author":"Chaudhuri","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib122","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib123","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused updates to the asthma management guidelines: a report from the\u00a0national asthma education and prevention program coordinating committee expert panel working group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.1998.tb04930.x","article-title":"WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic disease","volume":"53","author":"Bousquet","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib125","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib126","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.5415\/apallergy.2021.11.e32","article-title":"Clinical evaluation of rush immunotherapy using house dust mite allergen in Japanese asthmatics","volume":"11","author":"Uchida","year":"2021","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib127","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.alit.2023.02.006_bib128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1183\/09031936.01.00065801","article-title":"Improved asthma control with budesonide\/formoterol in a single inhaler, compared with budesonide alone","volume":"18","author":"Zetterstr\u00f6m","year":"2001","journal-title":"Eur Respir J"},{"issue":"6 Pt 1","key":"10.1016\/j.alit.2023.02.006_bib129","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1067\/mai.2000.105711","article-title":"Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial","volume":"105","author":"Kavuru","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.rmed.2005.09.006","article-title":"Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate","volume":"100","author":"Lundb\u00e4ck","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2009.09.011","article-title":"Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma","volume":"125","author":"Kelly","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.02.006_bib132","first-page":"CD006924","article-title":"Inhaled steroids with and without regular formoterol for asthma: serious adverse events","volume":"9","author":"Janjua","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2023.02.006_bib133","doi-asserted-by":"crossref","first-page":"106126","DOI":"10.1016\/j.rmed.2020.106126","article-title":"Short-term oral corticosteroids for initial treatment of moderate-to- severe persistent asthma: a double-blind, randomized, placebo-controlled trial","volume":"172","author":"Liang","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2023.02.006_bib134","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2169\/internalmedicine.56.7251","article-title":"Self-assessment of Allergic Rhinitis and Asthma (SACRA) questionnaire-based allergic rhinitis treatment improves asthma control in asthmatic patients with allergic rhinitis","volume":"56","author":"Yasuo","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.alit.2023.02.006_bib135","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1014350","article-title":"Effect of bronchoconstriction on airway remodeling in asthma","volume":"364","author":"Grainge","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2023.02.006_bib136","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/all.13374","article-title":"Identification of patterns of factors preceding severe or life-threatening asthma exacerbations in a nationwide study","volume":"73","author":"Tanaka","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2023.02.006_bib137","first-page":"CD001284","article-title":"Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma","volume":"1","author":"Kirkland","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2023.02.006_bib138","first-page":"CD002742","article-title":"Addition of intravenous aminophylline to inhaled beta(2)-agonisits in adult with acute asthma","volume":"12","author":"Nair","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2023.02.006_bib139","first-page":"CD001117","article-title":"Self-management education and regular practitioner review for adults with asthma","volume":"1","author":"Gibson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2023.02.006_bib140","first-page":"CD000195","article-title":"Corticosteroids for preventing relapse following acute exacerbations of asthma","volume":"3","author":"Rowe","year":"2007","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893023000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893023000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:13:49Z","timestamp":1761156829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893023000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1323893023000102"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2023.02.006","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Executive summary: Japanese guidelines for adult asthma (JGL) 2021","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}